InvestorsHub Logo
Followers 3
Posts 629
Boards Moderated 0
Alias Born 03/31/2010

Re: mattysimone post# 27347

Thursday, 07/28/2011 11:33:33 PM

Thursday, July 28, 2011 11:33:33 PM

Post# of 129051
EVERYONE READ:
I know there are some people that are still hesitant to purchase shares of CBIS but please consider the following.

-Last time I talked to Mark from Investor Relations he told me that Cannabis Science was receiving a handful of phone calls from people that wanted to pursue business with them, and others that wanted to purchase their cannabis based products. He said there was plenty of interest from other countries specifically Europe that were interested in doing business with them. But Mark said that the business potential for Cannabis Science is too large to share its innovations with anyone else. I asked Mark what he thought about GWPharmaceuticals (based in Europe) which is an enormous manufacturer of cannabis based products specifically Sativex, which made them so successful. Even more, he said that Cannabis Science is going to be better than GWP because its formulas do not trigger any health irritations like Sativex does. Lastly, he said that it is much easier to do business through outsource countries because the approval laws are much lighter than the US. So CBIS is always open to doing business in other countries.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.